← Back to headlines
GSK's lung cancer drug shows extended survival in China trials
GSK's partner Hansoh has announced a successful late-stage clinical trial for its lung cancer drug in China, with new reports indicating the drug helps patients live longer.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
bloombergFrench30d ago
GSK Says Lung Cancer Drug Helps Patients in China Live Longer - Bloomberg.com
GSK Says Lung Cancer Drug Helps Patients in China Live Longer Bloomberg.com
Read full article →seeking-alphaFrench30d ago
GSK partner Hansoh posts late-stage trial win for lung cancer drug in China
Read full article →Coverage Timeline
First report: seeking-alpha · 10 Jul, 11:29|Full coverage: 2 · 19m|Window: 19m
Left-leaningCenterRight-leaning
